Get started
Author

Laiba Jalal

Observed institution: Dow University of Health Sciences
ORCID: 0009-0003-4147-3138
Observed ORCID: 0009-0003-4147-3138
OpenAlex ID: A5118971094
FDA Approves First Targeted Treatment for Cerebrotendinous Xanthomatosis: A Perspective on a Landmark in Rare Lipid Storage Disease Therapy
2025 · Laiba Jalal, Areeba Aamir Ali Basaria, et al. · Health Science Reports · 2
PDF
CRISPR-Cas9 gene editing for hereditary angioedema: current treatments and emerging therapies
2025 · Laiba Jalal, Muskan Asim Taimuri, et al. · Annals of Medicine and Surgery · 2
Crovalimab: A Novel Approach in the Management of Paroxysmal Nocturnal Hemoglobinuria
2025 · Laiba Jalal, Marium Ahmed, et al. · Health Science Reports · 1
PDF
Temporal trends and socio-demographic disparities in COPD–lung cancer co-occurrence mortality in the United States: a 22 year analysis (1999–2020)
2026 · Abdullah Nadeem, Syed Muhammad Asjad Rizvi, et al. · Journal of Cancer Research and Clinical Oncology
Granzyme B in age-related macular degeneration: mechanistic insights and therapeutic perspectives
2026 · Muhammad Mohid Haroon, Laiba Akram, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology
Evaluating the Impact of Semaglutide on Stroke Risk Reduction in Cardiovascular High-Risk Populations: A Systematic Review and Meta-analysis
2025 · Laiba Nasir, Laiba Jalal, et al. · European Journal of Therapeutics
PDF
Evolving Trends and Disparities in Chronic Kidney Disease and Sepsis-Related Mortality in the United States from 1999 to 2023
2025 · Laiba Jalal, Turba Naz, et al. · Research Square
PDF
Dental Anxiety Among Patients Undergoing Extraction of Teeth
2024 · Gulsanga Shams, Bushra Mehboob, et al. · Pakistan Oral & Dental Journal
Works count: 9
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type